Benralizumab [1044511-01-4]

TargetMol Chemicals

Benralizumab

9

1044511-01-4

Antibody

Research Use Only

Benralizumab

SDS-PAGE:95% SEC-HPLC:95%

Benralizumab (MEDI-563) is a monoclonal antibody targeting the interleukin-5 receptor alpha (IL-5Ralpha). It enhances antibody-dependent cell-mediated cytotoxicity, leading to a rapid depletion of eosinophils. Benralizumab is used for severe eosinophilic asthma and can be employed to prevent exacerbations of chronic obstructive pulmonary disease.

3 years

-20°C

12352203